Insmed stock forecast
Insmed (IM8N) Stock Forecast & Price Target
IM8N Analyst Ratings
IM8N Stock 12 Month Forecast
Average Price Target
CHF160.09▲(74.64% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Leonid Timashev | RBC Capital | CHF163.87 | buy | 78.76%Upside | Reiterated | 11/17/26 | ||
| Maxwell Skor | Morgan Stanley | CHF179.00 | buy | 95.27%Upside | Reiterated | 11/13/26 | ||
| Gavin Clark-Gartner | Evercore ISI | CHF142.86 | buy | 55.85%Upside | Reiterated | 11/05/26 | ||
| Matthew Caufield | H.C. Wainwright | CHF184.88 | buy | 101.68%Upside | Initiated | 11/04/26 | ||
| Graig Suvannavejh | Mizuho Securities | CHF129.41→CHF132.78 | buy | 44.84%Upside | Reiterated | 11/03/26 | ||
| Conor MacKay | BMO Capital | CHF161.35 | buy | 76.01%Upside | Reiterated | 11/02/26 | ||
| Eliana Merle | Barclays | CHF173.95 | buy | 89.76%Upside | Reiterated | 11/02/26 | ||
| Leerink Partners | CHF176.47→CHF166.39 | buy | 81.51%Upside | Reiterated | 11/02/26 | |||
| Vamil Divan | Guggenheim | CHF172.27→CHF168.91 | buy | 84.26%Upside | Reiterated | 11/01/26 | ||
| Ashwani Verma | UBS | CHF144.54 | buy | 57.68%Upside | Reiterated | 10/30/26 | ||
| Andrea Newkirk | Goldman Sachs | CHF157.99→CHF163.03 | buy | 77.85%Upside | Reiterated | 10/30/26 | ||
| Adam Walsh | Roth MKM | CHF166.39→CHF171.43 | buy | 87.01%Upside | Reiterated | 10/29/26 | ||
| Tiago Fauth | Raymond James | CHF157.15→CHF145.38 | buy | 58.60%Upside | Reiterated | 10/20/26 | ||
| Benjamin Burnett | Wells Fargo | CHF142.02 | buy | 54.93%Upside | Assigned | 10/13/26 | ||
| Andy Chen | Wolfe Research | ― | hold | ― | Downgraded | 10/12/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Leonid TimashevRBC Capital | BuyReiteratedCHF163.87 | 11/17/26 | 78.76%Upside | ||
| Maxwell SkorMorgan Stanley | BuyReiteratedCHF179.00 | 11/13/26 | 95.27%Upside | ||
| Gavin Clark-GartnerEvercore ISI | BuyReiteratedCHF142.86 | 11/05/26 | 55.85%Upside | ||
| Matthew CaufieldH.C. Wainwright | BuyInitiatedCHF184.88 | 11/04/26 | 101.68%Upside | ||
| Graig SuvannavejhMizuho Securities | BuyReiteratedCHF129.41→CHF132.78 | 11/03/26 | 44.84%Upside | ||
| Conor MacKayBMO Capital | BuyReiteratedCHF161.35 | 11/02/26 | 76.01%Upside | ||
| Eliana MerleBarclays | BuyReiteratedCHF173.95 | 11/02/26 | 89.76%Upside | ||
| BuyReiteratedCHF176.47→CHF166.39 | 11/02/26 | 81.51%Upside | |||
| Vamil DivanGuggenheim | BuyReiteratedCHF172.27→CHF168.91 | 11/01/26 | 84.26%Upside | ||
| Ashwani VermaUBS | BuyReiteratedCHF144.54 | 10/30/26 | 57.68%Upside | ||
| Andrea NewkirkGoldman Sachs | BuyReiteratedCHF157.99→CHF163.03 | 10/30/26 | 77.85%Upside | ||
| Adam WalshRoth MKM | BuyReiteratedCHF166.39→CHF171.43 | 10/29/26 | 87.01%Upside | ||
| Tiago FauthRaymond James | BuyReiteratedCHF157.15→CHF145.38 | 10/20/26 | 58.60%Upside | ||
| Benjamin BurnettWells Fargo | BuyAssignedCHF142.02 | 10/13/26 | 54.93%Upside | ||
| Andy ChenWolfe Research | HoldDowngraded | 10/12/26 | ― |
Best Analysts Covering Insmed
Copying Jessica Fye's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +21.53% per trade.
Copying Tiago Fauth's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +81.37% per trade.
Copying Jessica Fye's trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +91.35% per trade.
IM8N Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 51 | 46 | 42 | 40 | 36 |
| Buy | 8 | 14 | 15 | 12 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 59 | 60 | 57 | 53 | 39 |
In the current month, IM8N has received 38 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IM8N average Analyst price target in the past 3 months is 160.09.
IM8N Financial Forecast
IM8N Earnings Forecast
Next quarter’s earnings estimate for IM8N is -CHF 0.25 with a range of -CHF 0.75 to CHF 0.13. The previous quarter’s EPS was -CHF 0.39. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
IM8N Sales Forecast
Next quarter’s sales forecast for IM8N is CHF 507.38M with a range of CHF 474.80M to CHF 544.27M. The previous quarter’s sales results were CHF 440.71M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

